Buy or sell Quartet stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Quartet Stock
Technology-Enabled behavioral health
About Quartet Stock
Investors
Deerfield Capital Management
F-Prime Capital Partners
PharmEasy, Devoted Health, SonderMind, Flywire, Quartet, Caribou Biosciences, Unison Home Ownership Investors, Stride Health
GV
Uber, Robinhood, Jet, Impossible Foods, Slack, Snyk, DocuSign, Olive, Cloudera, Farmers Business Network
Oak HC/FT
Devoted Health, Olive, Noom, Paxos, Rapyd, Quartet, Poynt, Truepill, Maven Clinic, Trōv
Polaris Partners
Freenome, Automattic, Club Factory, OM1, Egnyte, Quartet, Impinj, VeraCode, Xant, Drizly
Funding History
| March 2015 | $7.0M |
|---|---|
| April 2016 | $40.0M |
| January 2018 | $45.0M |
| June 2019 | $60.0M |
Management
Chief Executive Officer
David Wennberg, MD, MPH
Chief Mental Health Officer
Robert Accordino, MD, MSc
Chief Product Officer
Sarah Donnelly
Chief People Strategy Officer
Ingrid Kessler
Chief Operating Officer
Kevin Kumler
Chief Medical Officer
David Lim, MD, PhD
Chief Revenue Officer
Nancy Powers
Press
Business Insider - Oct, 2 2019
MobiHealthNews - Jun, 17 2019
TechCrunch - Oct, 5 2018
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Quartet or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
